Humana Management

Management criteria checks 3/4

Humana's CEO is Bruce Broussard, appointed in Jan 2013, has a tenure of 11.33 years. total yearly compensation is $16.33M, comprised of 9% salary and 91% bonuses, including company stock and options. directly owns 0.073% of the company’s shares, worth $28.20M. The average tenure of the management team and the board of directors is 2.9 years and 4.3 years respectively.

Key information

Bruce Broussard

Chief executive officer

US$16.3m

Total compensation

CEO salary percentage	9.0%
CEO tenure	11.3yrs
CEO ownership	0.07%
Management average tenure	2.9yrs
Board average tenure	4.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Bruce Broussard's remuneration changed compared to Humana's earnings?
Date	Total Compensation	Salary	Company Earnings
Mar 31 2024	n/a	n/a	US$2b
Dec 31 2023	US$16m	US$1m	US$2b
Sep 30 2023	n/a	n/a	US$3b
Jun 30 2023	n/a	n/a	US$3b
Mar 31 2023	n/a	n/a	US$3b
Dec 31 2022	US$17m	US$1m	US$3b
Sep 30 2022	n/a	n/a	US$3b
Jun 30 2022	n/a	n/a	US$3b
Mar 31 2022	n/a	n/a	US$3b
Dec 31 2021	US$17m	US$1m	US$3b
Sep 30 2021	n/a	n/a	US$3b
Jun 30 2021	n/a	n/a	US$2b
Mar 31 2021	n/a	n/a	US$4b
Dec 31 2020	US$16m	US$1m	US$3b
Sep 30 2020	n/a	n/a	US$4b
Jun 30 2020	n/a	n/a	US$4b
Mar 31 2020	n/a	n/a	US$3b
Dec 31 2019	US$17m	US$1m	US$3b
Sep 30 2019	n/a	n/a	US$3b
Jun 30 2019	n/a	n/a	US$3b
Mar 31 2019	n/a	n/a	US$2b
Dec 31 2018	US$16m	US$1m	US$2b
Sep 30 2018	n/a	n/a	US$2b
Jun 30 2018	n/a	n/a	US$1b
Mar 31 2018	n/a	n/a	US$2b
Dec 31 2017	US$20m	US$1m	US$2b

Compensation vs Market: Bruce's total compensation ($USD16.33M) is above average for companies of similar size in the UK market ($USD5.61M).

Compensation vs Earnings: Bruce's compensation has been consistent with company performance over the past year.

CEO

Bruce Broussard (61 yo)

11.3yrs

Tenure

US$16,327,384

Compensation

Mr. Bruce Dale Broussard has been Independent Director at HP Inc. since 2021. He serves as the Member of Advisory Board of HealthQuest Capital. Mr. Bruce serves as the President and Chief Executive Officer...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Bruce Broussard	CEO & Director	11.3yrs	US$16.33m	0.073% $ 28.2m
Susan Diamond	Chief Financial Officer	2.9yrs	US$4.73m	0.0070% $ 2.7m
Joseph Ventura	Chief Legal Officer	5.3yrs	US$3.10m	0.0060% $ 2.3m
George Renaudin	President of Medicare & Medicaid	1.3yrs	US$3.11m	0.0024% $ 915.5k
Sanjay Shetty	President of CenterWell	1.2yrs	US$4.58m	0.00014% $ 53.9k
James Rechtin	President & COO	less than a year	no data	0.000010% $ 3.8k
John-Paul Felter	Senior VP	1.8yrs	no data	0.00019% $ 73.1k
Eric Tagliere	Senior VP & CTO	less than a year	no data	no data
Samir Deshpande	Chief Information Officer	3.3yrs	no data	0.010% $ 4.0m
Timothy Huval	Chief Administrative Officer	4.8yrs	US$3.73m	0.0061% $ 2.4m
Lisa Stoner	Vice President of Investor Relations	no data	no data	no data
Vishal Agrawal	Chief Strategy & Corporate Development Officer	5.4yrs	no data	0.0090% $ 3.5m

2.9yrs

Average Tenure

50.5yo

Average Age

Experienced Management: 0J6Z's management team is considered experienced (2.9 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Bruce Broussard	CEO & Director	11.3yrs	US$16.33m	0.073% $ 28.2m
Kurt Hilzinger	Independent Chairman of the Board	20.8yrs	US$601.30k	0.016% $ 6.2m
Karen Katz	Independent Director	4.7yrs	US$346.55k	0.00049% $ 188.5k
Frank D'Amelio	Independent Director	20.7yrs	US$363.55k	0.017% $ 6.6m
Jorge Mesquita	Independent Director	3.3yrs	US$312.41k	0.0018% $ 684.7k
Brad Smith	Independent Director	1.7yrs	US$311.07k	0.00032% $ 123.1k
Wayne Frederick	Independent Director	4.3yrs	US$364.87k	0.00037% $ 142.3k
David Feinberg	Independent Director	2.2yrs	US$321.52k	0.00037% $ 142.3k
Marcy Klevorn	Independent Director	3.3yrs	US$351.94k	0.00036% $ 138.5k
John Garratt	Independent Director	4.3yrs	US$326.03k	0.0010% $ 400.1k
RaQuel Bono	Independent Director	3.7yrs	US$345.03k	0.00033% $ 126.9k

4.3yrs

Average Tenure

61yo

Average Age

Experienced Board: 0J6Z's board of directors are considered experienced (4.3 years average tenure).

Humana Management

Management criteria checks 3/4

Key information

Recent management updates

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc. Announces Management Changes

Chief Financial Officer recently sold US$415k worth of stock

High number of new directors

Independent Director recently sold US$7.5m worth of stock

Recent updates

First quarter 2024 earnings released: EPS: US$6.13 (vs US$9.91 in 1Q 2023)

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Dividend of US$0.89 announced

Humana Inc. Declares Cash Dividend, Payable on July 26, 2024

Humana Inc. to Report Q1, 2024 Results on Apr 24, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc. Declares Cash Dividend, Payable on April 26, 2024

Humana Inc. Provides Earnings Guidance for 2024

Humana Announces Limited Layoffs

Upcoming dividend of US$0.89 per share at 0.8% yield

Cigna Reportedly Ends Humana Merger Talks

Cigna, Humana Reportedly in Talks for Merger

Humana Inc. Declares Cash Dividend, Payable on January 26, 2024

Third quarter 2023 earnings released: EPS: US$6.74 (vs US$9.44 in 3Q 2022)

Humana Inc. Announces Management Changes

Humana Inc. to Report Q3, 2023 Results on Nov 01, 2023

Humana Inc. (NYSE:HUM) agreed to acquire Senior-focused primary care centers in Texas and Nevada of Cano Health, LLC for $66.7 million.

Upcoming dividend of US$0.89 per share at 0.7% yield

Centerwell Senior Primary Care Introduces In-Home Primary Care

Humana Inc. Declares Cash Dividend, Payable on October 27, 2023

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2023

Second quarter 2023 earnings released: EPS: US$7.70 (vs US$5.50 in 2Q 2022)

Humana Inc. to Report Q2, 2023 Results on Aug 02, 2023

Upcoming dividend of US$0.89 per share at 0.8% yield

Chief Financial Officer recently sold US$415k worth of stock

First quarter 2023 earnings released

Upcoming dividend of US$0.89 per share at 0.7% yield

High number of new directors

Humana Inc. Declares Cash Dividend, Payable on April 28, 2023

Full year 2022 earnings released: EPS: US$22.20 (vs US$22.79 in FY 2021)

Humana Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2023

Humana Inc. to Report Q4, 2022 Results on Feb 01, 2023

Independent Director recently sold US$7.5m worth of stock

Upcoming dividend of US$0.79 per share

President recently sold US$3.7m worth of stock

Segment President of Retail recently sold US$4.0m worth of stock

Third quarter 2022 earnings released: EPS: US$9.44 (vs US$11.91 in 3Q 2021)

Humana Inc. Provides Earning Guidance for Fiscal Year 2022

Humana Inc. Declares Cash Dividend to Stockholders, Payable on January 27, 2023

Humana, USAA Launch New Medicare Advantage Plan Tailored to Veterans’ Needs

Humana Inc. to Report Q3, 2022 Results on Nov 02, 2022

Humana Reportedly Among Firms Looking to Buy Cano Health

Chief Legal Officer recently sold US$621k worth of stock

Upcoming dividend of US$0.79 per share

Humana Elects Brad D. Smith to Board of Directors

Humana Inc. Declares Payment of Quarterly Dividend to Stockholders, October 28, 2022

Humana Inc. (NYSE:HUM) agreed to acquire Substantially All of the Assets of Inclusa, Inc.

Second quarter 2022 earnings released: EPS: US$5.50 (vs US$4.57 in 2Q 2021)

Humana Inc. Reports Impairment Charges for the Second Quarter Ended June 30, 2022

Humana Inc. to Report Q2, 2022 Results on Jul 27, 2022

Humana Inc. Announces Management Changes

Upcoming dividend of US$0.79 per share

Chief Administrative Officer recently sold US$1.5m worth of stock

First quarter 2022 earnings released: EPS: US$7.33 (vs US$6.42 in 1Q 2021)

Humana Inc. Declares Payment of Quarterly Dividend to Stockholders, Payable on July 29, 2022

Humana Inc. to Report Q1, 2022 Results on Apr 27, 2022

Upcoming dividend of US$0.79 per share

Humana Inc. Announces Executive Changes, Effective March 31, 2022

Humana Board Declares Payment of Quarterly Dividend to Stockholders, Payable on April 29, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Humana Inc. Provides Earnings Guidance for the Year Ending December 31, 2022

Investor sentiment deteriorated over the past week

Upcoming dividend of US$0.70 per share

President recently sold US$4.0m worth of stock

Third quarter 2021 earnings released: EPS US$11.91 (vs US$10.13 in 3Q 2020)

Independent Director recently sold US$1.9m worth of stock

Upcoming dividend of US$0.70 per share

Humana Inc. (NYSE:HUM) completed the acquisition of the remaining 60% stake in Kindred Healthcare, LLC from TPG Capital, L.P., and Welsh, Carson, Anderson & Stowe.